Henry P.
Wood
a,
Nicola J.
Baxter
ab,
F. Aaron
Cruz-Navarrete
a,
Clare R.
Trevitt
a,
Andrea M.
Hounslow
a and
Jonathan P.
Waltho
*ab
aKrebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, S10 2TN, UK. E-mail: j.waltho@sheffield.ac.uk; Tel: +44 114 22717
bManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, Manchester, M1 7DN, UK
First published on 15th January 2021
Manipulation of enzyme behaviour represents a sustainable technology that can be harnessed to enhance the production of valuable metabolites and chemical precursors. β-Glucose 1,6-bisphosphate (βG16BP) is a native reaction intermediate in the catalytic cycle of β-phosphoglucomutase (βPGM) that has been proposed as a treatment for human congenital disorder of glycosylation involving phosphomannomutase 2. Strategies to date for the synthesis of βG16BP suffer from low yields or use chemicals and procedures with significant environmental impacts. Herein, we report the efficient enzymatic synthesis of anomer-specific βG16BP using the D170N variant of βPGM (βPGMD170N), where the aspartate to asparagine substitution at residue 170 perturbs the coordination of a catalytic magnesium ion. Through combined use of NMR spectroscopy and kinetic assays, it is shown that the weakened affinity and reactivity of βPGMD170N towards βG16BP contributes to the pronounced retardation of the second step in the two-step catalytic cycle, which causes a marked accumulation of βG16BP, especially at elevated MgCl2 concentrations. Purification, employing a simple environmentally considerate precipitation procedure requiring only a standard biochemical toolset, results in a βG16BP product with high purity and yield. Overall, this synthesis strategy illustrates how manipulation of the catalytic magnesium coordination of an enzyme can be utilised to generate large quantities of a valuable metabolite.
![]() | ||
Fig. 1 In vitro phosphorylation and catalytic cycle of βPGM. AcP phosphorylates βPGM generating βPGMP (phosphorylated on residue D8) in a Mg2+-independent reaction (green ink). In the Mg2+-dependent catalytic cycle (black ink), Step 1 involves phosphoryl transfer from βPGMP to the βG1P substrate forming the βG16BP intermediate, whereas Step 2 comprises phosphoryl transfer from βG16BP (bound in the alternate orientation) to βPGM forming the G6P product and regeneration of βPGMP. In the phosphorylated glucosaccharide structures, 1-phosphate groups are coloured red and 6-phosphate groups are coloured blue. The black arrows denote the dominant direction of the corresponding reversible reactions. In the absence of the βG1P substrate, βPGMP has a half-life of 30 s and hydrolyses readily to βPGM liberating inorganic phosphate (Pi).12 |
βG16BP has also been identified as a potential pharmacological chaperone for the management of a human congenital disorder of glycosylation involving phosphomannomutase 2.20 Acting as a weakly binding competitive inhibitor, βG16BP is able to rescue the compromised activity of pathological variants of phosphomannomutase 2 by stabilising the protein fold. Therefore, further investigations of phosphomannomutase 2 and of βPGM are reliant on the availability of substantial quantities of βG16BP. Three strategies have been reported previously for the synthesis of βG16BP; however, each of these methods either delivers low yields or uses chemicals and procedures with significant environmental impacts. Firstly, the chemical synthesis of βG16BP from α-glucose involves an eight-step protocol, requiring considerable time and technical expertise, together with the use of harmful and environmentally hazardous reagents.12 Low yields are obtained, since the β-anomer must be selected carefully on the basis of solubility from a racemic mixture of glucosaccharide products. Secondly, an enzymatic production method utilises a non-native reaction of phosphofructokinase to generate βG16BP from βG1P using adenosine triphosphate as the phosphoryl donor.17,20 Purification of the product, though, cannot be achieved simply using precipitation procedures, since contaminating adenosine diphosphate co-precipitates with βG16BP,21 and therefore ion-exchange HPLC purification is required. The use of HPLC columns is inherently damaging to the environment owing to the use of triethylammonium bicarbonate as a volatile buffer mobile phase, which during its production results in the release of large quantities of carbon dioxide.22 Thirdly, an extraction method involves the removal of βG16BP from a variant of βPGM that co-purifies with a stoichiometric quantity of the molecule.18 This method suffers from low yields, since it relies on very high recombinant βPGM production levels, and requires a week-long protein growth and purification procedure for each new batch of βG16BP. The limited availability of βG16BP therefore represents a significant barrier to the structural, kinetic and therapeutic investigations of phosphomutase enzymes. Herein, we describe a room-temperature, enzymatic method using the D170N variant of βPGM (βPGMD170N) for the production of 100% anomer-specific βG16BP, which requires only micromolar quantities of enzyme and a simple environmentally considerate purification procedure that can be performed easily by a non-chemist over the course of two days. Through combined use of NMR spectroscopy and kinetic assays, it is shown that the weakened affinity and reactivity of βPGMD170N towards βG16BP contributes to the pronounced retardation of the second step in the two-step catalytic cycle, which causes a marked accumulation of βG16BP, especially at elevated MgCl2 concentrations. More generally, this enzymatic synthesis strategy illustrates how manipulation of catalytic magnesium coordination can be utilised to generate large quantities of a valuable metabolite.
βPGM has two phosphoryl transfer steps in its catalytic cycle: Step 1 comprises phosphoryl transfer from βPGMP to the βG1P substrate forming the βG16BP reaction intermediate, whereas Step 2 involves phosphoryl transfer from βG16BP to βPGM forming the G6P product and regeneration of βPGMP (Fig. 1). When wild-type βPGM (βPGMWT) is incubated in the presence of Mg2+ ions, with 20 mM AcP as the phosphorylating agent and 10 mM βG1P as a substrate, βG16BP generated in the catalytic cycle does not accumulate to detectable levels when monitored using 31P NMR experiments.18 Instead, βG16BP rebinds the enzyme with micromolar affinity in the alternate orientation, for the Step 2 reaction. Thus, the tight binding and high reactivity of βG16BP maintain a low steady state concentration, which precludes the harvesting of this species in useful quantities. The crystal structures of substrate-free βPGMWT (PDB: 6YDL23) and of the βPGMWTP analogue complex (βPGMWT:BeF3 complex, PDB: 2WFA15) indicate that the catalytic magnesium ion (Mgcat) is coordinated through three enzyme atoms in the former and four phospho-enzyme atoms in the latter (Fig. 2). Therefore, the differential coordination of Mgcat provides an appropriate target with which to manipulate βPGM to shift the balance in the rate constants of Step 1 and Step 2 so that βG16BP will accumulate to a greater extent. Two potential strategies emerged where Step 2 could be retarded with respect to Step 1, which involved either performing the reactions of the catalytic cycle under Mg2+-free conditions or perturbing Mgcat coordination through point mutation to alter its binding properties. In either scenario, it was hypothesised that βPGM with a compromised Mgcat site could be phosphorylated efficiently by reactive phosphorylating agents such as AcP, thereby generating βPGMP and subsequent reaction with βG1P to produce βG16BP in Step 1 (Fig. 1). In contrast, phosphorylation of βPGM by βG16BP in Step 2 is less likely under these circumstances, which would lead to an accumulation of the reaction intermediate that could be harvested.
![]() | ||
Fig. 2 Comparison of octahedral Mgcat coordination in βPGMWTP (Step 1) and βPGMWT (Step 2). (A) A model of βPGMWTP derived from the crystal structure of the βPGMWT:BeF3 complex (PDB: 2WFA15) showing Mgcat coordination. The ligands comprise a carboxylate oxygen atom of residue D170, the carbonyl oxygen atom of residue D10 and two water molecules (indicated by numbers), together with the carboxylate oxygen atom and a phosphate oxygen atom of the D8 aspartyl phosphate moiety, creating bidentate coordination of Mgcat in a six-membered ring of atoms. (B) The crystal structure of substrate-free βPGMWT (PDB: 6YDL23) showing Mgcat coordination. The ligands involve a carboxylate oxygen atom of residue D8, a carboxylate oxygen atom of residue D170, the carbonyl oxygen atom of residue D10 and three water molecules (indicated by numbers). Mgcat is depicted as a green sphere, water molecules are illustrated as red spheres and metal ion coordination is shown as black dashes. |
To explore whether AcP is able to phosphorylate Mgcat-free βPGMWT, 31P NMR experiments were acquired to measure the change in AcP concentration over time in the presence and absence of 300 μM βPGMWT. The addition of βPGMWT resulted in a 25% increase in the rate of AcP hydrolysis (Fig. 3A), implying that βPGMWTP is generated and hydrolysed in the absence of Mgcat. Consequently, the Step 1 reaction between Mgcat-free βPGMWT and 10 mM βG1P in the presence of 50 mM AcP, together with the Step 2 production of G6P, was monitored using 31P NMR time-course experiments. However, there was no detectable accumulation of βG16BP (Fig. 4A–C) and the appearance of G6P product proceeded with a rate constant of 6.7 × 10−3 s−1, which is 4 orders of magnitude smaller than the rate constant observed in the presence of 5 mM MgCl2.18 Hence, the observed enzymatic activity may simply arise due to the presence of very low levels of residual Mg2+ ions associated with the reagents. Taken together, these results indicate that both Mgcat-bound βPGMWTP and Mgcat-free βPGMWTP can be generated by AcP, but both the Step 1 and Step 2 phosphoryl transfer reactions are seriously impaired by the absence of Mgcat.
![]() | ||
Fig. 3 Kinetic experiments involving βPGMWT and βPGMD170N. (A) Effect of βPGMWT and βPGMD170N on the hydrolysis of AcP monitored using 31P NMR time-course experiments. AcP hydrolysis profiles were derived from normalised peak intensities obtained from reactions containing 50 mM AcP in 200 mM K+ HEPES buffer (pH 7.2) without MgCl2 (white circles) and separately in the presence of 300 μM βPGMWT (black circles) or presence of 300 μM βPGMD170N (green circles). (B and C) Activity of βPGMD170N with increasing MgCl2 concentration monitored using 31P NMR time-course experiments. Samples contained 5 μM βPGMD170N and 10 mM βG1P in 200 mM K+ HEPES buffer (pH 7.2), 10% 2H2O (v/v) and 1 mM TSP with increasing concentrations of MgCl2 (5, 10, 20, 30, 50, 100 mM). The reactions were initiated by and timed from the addition of 20 mM AcP. Initial rate measurements for (B) the Step 1 production of βG16BP and (C) the Step 2 production of G6P were obtained from linear least-squares fitting of normalised integral values of the 31P resonances of βG16BP and G6P present in the spectra. Subsequent fitting of the Step 2 initial rate values to eqn (1) using an in-house Python non-linear least squares fitting program yielded an apparent Km (Mg2+) = 27 ± 4 mM. (D) Kinetic profiles for the conversion of βG1P to G6P by βPGMWT monitored using a G6PDH coupled assay. Reactions were conducted in 200 mM K+ HEPES buffer (pH 7.2) containing 5 mM MgCl2, 1 mM NAD+, 5 U mL−1 G6PDH, 50 μM βG1P and 5 nM βPGMWT with either 1 μM of the final βG16BP product (red circles) or 8 mM AcP (pink circles) as the phosphorylating agent. For clarity, only half of the acquired data points have been included. |
Given the low rate of βG16BP production in the absence of Mg2+ ions in the reaction buffer, a more subtle modification of the enzyme Mgcat site was engineered. In βPGMWT, Mgcat is coordinated octahedrally by a carboxylate oxygen atom of residue D8, a carboxylate oxygen atom of residue D170 and the carbonyl oxygen atom of residue D10, together with three water molecules. In βPGMWTP, one of the water molecules (water 3) is displaced by a phosphate oxygen atom of the D8 aspartyl phosphate moiety, creating bidentate coordination of Mgcat in a six-membered ring of atoms (Fig. 2). Point mutations involving residue D8 have been reported to result in the complete loss of measurable catalytic activity.19 Therefore, perturbation of Mgcat was achieved through the generation of the D170N variant (βPGMD170N), where the carboxamide group of residue N170 retains an oxygen atom with which to coordinate Mgcat, but the sidechain is not charged. Accordingly, the reaction of βPGMD170N with 10 mM βG1P and 20 mM AcP in the presence of 100 mM MgCl2 was monitored using 31P NMR time-course experiments and, in contrast to βPGMWT, the βG16BP intermediate was observed to accumulate to a level comparable with the initial βG1P concentration (Fig. 4D and E). The G6P product was only generated to a measurable extent once the AcP concentration had reduced significantly (Fig. 4F). Hence, perturbation of Mgcat in βPGMD170N (in the presence of excess AcP) results in a substantial retardation of phosphorylation of βPGMD170N by βG16BP (Step 2) with respect to phosphorylation of βG1P by βPGMD170NP (Step 1), therefore allowing βG16BP to accumulate.
To investigate the source of the retardation of Step 2, glucose 6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49) coupled assay experiments were conducted to assess the ability of βPGMD170N to bind and convert the substrates of Step 2 (βG16BP) and Step 1 (βG1P). Initial rate measurements were recorded at increasing concentrations of βG16BP, which revealed that βPGMD170N had an apparent Km (βG16BP) = 150 ± 13 μM (Fig. S1A†). This value is 18-fold weaker than that measured for βPGMWT (Km (βG16BP) = 8.5 ± 0.3 μM (ref. 23)). Analogous experiments at increasing concentrations of βG1P indicated that βPGMD170N had an apparent Km (βG1P) = 6.9 ± 1.0 μM, which is similar in magnitude to the Km (βG1P) for βPGMWT (Km (βG1P) = 14.7 ± 0.5 μM (ref. 12)). These experiments also demonstrated that a similar level of βG1P inhibition was operating in βPGMD170N (apparent Ki (βG1P) = 1540 ± 170 μM) and βPGMWT (Ki (βG1P) = 1510 ± 100 μM (ref. 23)) (Fig. S1B†). The Km (Mg2+) value for the overall reaction of βG1P to G6P was also measured for βPGMD170N using increasing concentrations of MgCl2 (Fig. S2†). These experiments resulted in an apparent Km (Mg2+) = 690 ± 110 μM, which is only 4-fold weaker than that determined for βPGMWT using the same method (apparent Km (Mg2+) = 180 ± 40 μM). Overall, at 1 mM βG1P, 100 μM βG16BP and 5 mM MgCl2 the observed rate constant for the overall reaction of βG1P to G6P catalysed by βPGMD170N (kobs = 3.0 × 10−3 s−1) is 79000-fold smaller than that for βPGMWT (kobs = 237 s−1).
The observable accumulation of βG16BP in the 31P NMR spectra of the βPGMD170N-catalysed reaction (Fig. 4D–F) presented an opportunity to measure the effects of Mg2+ ion concentration on Step 1 and Step 2 independently within the same experiment (Fig. 1), although it should be noted that kinetic parameters obtained using 31P NMR methods and the G6PDH coupled assay differ significantly due to the effects of the different conditions employed.18,2331P NMR time-course experiments were therefore conducted at increasing concentrations of MgCl2 to measure simultaneously the initial rates of βG16BP production in Step 1 and G6P production in Step 2 (Fig. 3B and C). The initial rates of βG16BP production increased linearly with MgCl2 concentration and so could not be fitted to a Michaelis–Menten equation over the concentration range 5–100 mM (Fig. 3B), indicating that the affinity of βPGMD170N for Mgcat in Step 1 is low. Extraction of the initial rates of G6P production in Step 2 resulted in an apparent Km (Mg2+) = 27 ± 4 mM (Fig. 3C). These observations therefore reveal that βG16BP accumulation can be greatly enhanced by using elevated concentrations of Mg2+ ions. For βPGMD170N at 5 mM MgCl2, the initial rate of Step 1 (kobs = 9.0 × 10−3 s−1) is only 3-fold faster than that of Step 2 (kobs = 3.0 × 10−3 s−1), while at 100 mM MgCl2 Step 1 (kobs = 0.24 s−1) exceeds Step 2 (kobs = 1.2 × 10−2 s−1) by a factor of 20 (Fig. 3B, C and 4G, H). A control experiment employing elevated NaCl concentrations demonstrated that the increased initial rate of Step 1 at higher concentrations of MgCl2 is not caused by Cl− ions alone (Fig. 4I). Therefore, the Mg2+ ion concentration at which the production of βG16BP is performed has a strong bearing on its yield.
Taken together, this analysis demonstrates that the D170N point mutation causes a pronounced retardation of Step 2 together with a more modest change to Step 1. The reduced apparent Km value of βPGMD170N for βG16BP is in line with this behaviour. However, the substantially different apparent Km (Mg2+) values determined for Step 1 and Step 2 are not, which was surprising given the perturbation of the Mgcat binding site in βPGMD170N. One plausible explanation for these observations is that a Cl− ion binds in the active site in substrate-free βPGMD170N to mitigate the loss of the negative charge resulting from the D170N point mutation. The presence of a Cl− ion at the Mgcat binding site would rescue the binding of Mgcat but hamper the binding of βG16BP and the approach of its phosphodianion to the carboxylate group of D8 in Step 2. In contrast, AcP is able to generate βPGMD170NP in a Mgcat-independent manner (Fig. 1 and Fig. 3A) and the presence of the D8 aspartyl phosphate moiety will obviate the formation of the Mgcat–Cl moiety.
To obtain evidence for a putative Mgcat–halide moiety binding to substrate-free βPGMD170N, 10 mM NaF was added to substrate-free βPGMD170N containing 5 mM MgCl2 and 19F NMR experiments were recorded (Fig. 4J and K). A βPGMD170N-bound 19F species was observed with a chemical shift of −171 ppm, which corresponds to an analogous peak seen for substrate-free βPGMWT acquired under similar conditions.24 Elevation to 100 mM MgCl2 did not result in increased saturation of Mgcat, but instead reduced the 19F peak integral to 80% of its size at 5 mM MgCl2, suggesting that at higher concentrations, Cl− ions are displacing the F− ion bound at the Mgcat site (Fig. 4J and K). In the experiment containing 100 mM MgCl2, three free 19F species are present in solution that are separated by chemical shift differences of exactly 37 ppm. Free F− (−118 ppm) and free MgF+ (−155 ppm) have been assigned previously,24 whereas the peak resonating at −192 ppm is likely to be a free Mg–F–Mg3+species, based on the partitioning behaviour between discrete species as the MgCl2 concentration is increased. Comparison of the chemical shifts of the βPGMD170N-bound 19F species with those of the three free species suggests that it is closer in identity to MgF+. Therefore, the primary candidate for such an enzyme-bound species is a Mgcat–F moiety, which in turn provides supporting evidence for the binding of a Mgcat–Cl moiety to substrate-free βPGMD170N that would consequently play a role in the retardation of Step 2 relative to Step 1.
The large-scale generation of βG16BP by the βPGMD170N-catalysed reaction at high concentrations of MgCl2 thus presented an opportunity for harvesting significant quantities of this valuable compound and so a robust production protocol was devised. Recombinant βPGMD170N is overexpressed in high yields from Escherichia coli BL21(DE3) cells (>100 mg L−1) using routine culture techniques and is readily purified using a two-step protocol involving ion-exchange chromatography followed by a size-exclusion chromatography step. βPGMD170N can be stored at −20 °C for long periods and responds well to multiple freeze–thaw cycles, meaning that once purified, a batch of enzyme can be used for numerous βG16BP preparations. In order to characterise βPGMD170N further, 1H15N–TROSY NMR spectra were recorded using samples of 15N-βPGMD170N and 15N-βPGMWT. Comparison of the spectra revealed that βPGMD170N has a similar solution behaviour and overall protein fold to βPGMWT (Fig. S3†). The slow-exchange behaviour that arises in βPGMWT from cis–trans proline isomerisation at the K145-P146 peptide bond is also observable in βPGMD170N.23 Notably, around 15 peaks are present for βPGMD170N that are absent in the spectrum of βPGMWT. These additional peaks indicate that a backbone conformational exchange process, occurring on the millisecond timescale in βPGMWT, has been abolished in βPGMD170N.23
To assess the stability of βPGMD170N and to check for time-dependent reversion to βPGMWT by deamidation,25 a sample of βPGMD170N was incubated at 25 °C for 48 h and both 1H15N–TROSY NMR spectra and 31P NMR time-course experiments were acquired every 24 h. A comparison of 1H15N–TROSY spectra recorded for βPGMD170N preincubated at 25 °C for 0 h and 48 h shows a near-identical correspondence of peaks indicating that the incubation process has a negligible effect on the integrity of βPGMD170N (Fig. S4A†). In comparisons of βPGMD170N and βPGMWT1H15N–TROSY spectra, the absence of observable βPGMWT peaks in the βPGMD170N spectra indicates that reversion of βPGMD170N to βPGMWT through deamidation is not a process that occurs readily under these sample conditions (Fig. S4B and C†). Analysis of the 31P NMR time-course experiments for the equilibration of 10 mM βG1P with G6P catalysed by βPGMD170N (preincubated at 25 °C for 0 h, 24 h and 48 h) demonstrates a consistent behaviour of βG16BP production followed by conversion to G6P as product with no change in kobs, further confirming the stability of βPGMD170N (Fig. S5A†).
To mimic the effect of βPGMD170N reversion to βPGMWT through deamidation, a control 31P NMR time-course experiment was also conducted using a sample of βPGMD170N that had been spiked with 0.1% βPGMWT (Fig. S5B†). The kinetic profile shows an initial burst of G6P production by βPGMWT together with a decrease in the ratio of the βG16BP concentration at its maximum (βG16BPmax) to the concentration of G6P at its maximum (G6Pmax). The 31P NMR time-course experiments testing βPGMD170N stability revealed no burst of G6P production nor any change in either kobs or the βG16BPmax:G6Pmax ratio. Together, these results indicate that βPGMD170N does not undergo detectable deamidation to βPGMWT and is stable at 25 °C over a 48-hour time frame.
31P NMR time-course experiments were used to monitor the βPGMD170N-catalysed conversion of βG1P to G6P to determine the optimal point at which to harvest βG16BP. In a representative reaction (see Materials and Methods) the βG16BP concentration reached a maximum after 265 min at 25 °C. Following quenching of the reaction at this point, and removal of βPGMD170N, the solution was found to contain βG16BP alongside contaminants that included significant amounts of βG1P, G6P and inorganic phosphate (Pi), in a ratio of 1:
0.07
:
0.2
:
3.9, respectively. As substrates of βPGM, these phosphorylated impurities are undesirable, therefore the solution was subjected to a barium salt precipitation and ion-exchange protocol to obtain the sodium salt of βG16BP with high purity. Barium salts of phosphate species are relatively insoluble,26 and the difference in relative solubility of the βG16BP barium salt compared with those of βG1P and G6P was exploited to enable purification.27–29
To confirm the identity and assess the purity of the final βG16BP product, a sample of the fine powder was analysed using 1H, 13C and 31P NMR experiments (Fig. 5A–D). The identity of the resulting compound was established to be βG16BP by comparison of 1H and 13C chemical shifts with previously reported values.12 Glucose and maltose contaminants were identified in the sample using 1H chemical shifts and scalar coupling constants (BMRB: bmse000015, BMRB: bmse000017). Based on integral values of the anomeric proton signals and of the phosphorus signals in quantitative 1H and 31P NMR spectra, the βG16BP concentration was determined to be 67 mM, which represented 98% of the total phosphorylated glucosaccharide components and 72% of the total glucosaccharide components present in the final sample. βG1P, G6P and glucose comprised <1%, 1% and 3%, respectively, of the total glucosaccharide content. Maltose was present at a greater concentration in the sample (24%), but as a bystander in the reactions of βPGM, and not known to bind to phosphomannomutase 2, this contamination is unlikely to be problematic for users. Pi was also present at a concentration 2.9-fold higher than that of βG16BP. The glucose, maltose and Pi components, which were carried through into the final βG16BP product, are contaminants derived from the enzymatic synthesis of βG1P and would otherwise not be present if a purer source of βG1P were used. Residual HEPES buffer and acetate were also present as minor contaminants. The final yield for the βPGMD170N-catalysed conversion of βG1P to βG16BP was 33.6% and the yield for the overall conversion of maltose to βG16BP was 7.7%. Since the equilibrium for the enzymatic conversion of maltose to βG1P lies in favour of maltose, conducting the reactions for the maltose phosphorylase synthesis of βG1P and the βPGMD170N synthesis of βG16BP in a one-pot system is likely to lead to higher βG16BP yields. The removal of βG1P by βPGMD170N would drive the maltose reaction to produce more βG1P, which in turn would result in a greater overall yield of βG16BP. This approach has been demonstrated previously for the protocol involving maltose phosphorylase and phosphofructokinase.17 To demonstrate the biochemical effectiveness of the final βG16BP product at activating βPGMWT, a kinetic experiment was conducted using the G6PDH coupled assay. βPGMWT was mixed with the βG1P substrate and activated using either 1 μM βG16BP (produced using βPGMD170N) or 8 mM AcP as the phosphorylating agent. The kinetic profile obtained was linear for the βG16BP-containing reaction, but exhibited a lag phase when AcP was used (Fig. 3D). As βG16BP is the only phosphorylating agent known to induce linear initial kinetics in βPGM,23 this experiment provided a clear demonstration of the activity of the final βG16BP product.
![]() | ||
Fig. 5 NMR experiments recorded on a sample of the final βG16BP product, purified following its production by βPGMD170N and prepared in 100% 2H2O. (A) 1H spectrum showing βG16BP and other glucosaccharide species present in the sample. (B) A region of the 1H spectrum showing the anomeric proton glucosaccharide signals, together with their assignments. (C) 31P spectrum showing the two phosphorus signals of βG16BP (6-phosphate, 4.76 ppm (triplet) and 1-phosphate, 2.55 ppm (doublet)) and the signal corresponding to inorganic phosphate (Pi, 2.70 ppm (singlet), truncated for clarity). (D) Natural abundance 1H13C–HSQC spectra comparing the final βG16BP product (orange) with chemically synthesised βG16BP (blue).12 Peaks are labelled with carbon ring atom assignments. |
![]() | (1) |
![]() | (2) |
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/d0gc03290e |
This journal is © The Royal Society of Chemistry 2021 |